Home/Filings/4/0001144204-19-018081
4//SEC Filing

Shapiro David 4

Accession 0001144204-19-018081

CIK 0001270073other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 7:00 PM ET

Size

6.6 KB

Accession

0001144204-19-018081

Insider Transaction Report

Form 4
Period: 2019-04-01
Shapiro David
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-04-01$111.50/sh482$53,74340,061 total
  • Sale

    Common Stock

    2019-04-03$115.01/sh562$64,63639,499 total
Footnotes (2)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person.
  • [F2]This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1
  • filerCIK 0001559570

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 7:00 PM ET
Size
6.6 KB